GSA CAPITAL PARTNERS LLP - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 136 filers reported holding IMMUNITYBIO INC in Q2 2022. The put-call ratio across all filers is 1.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q4 2022$112
-100.0%
22,043
-74.0%
0.01%
-70.2%
Q2 2022$316,000
-32.3%
84,884
+2.0%
0.05%
-25.4%
Q1 2022$467,000
-40.6%
83,204
-35.6%
0.06%
-36.4%
Q4 2021$786,000129,2600.10%
Other shareholders
IMMUNITYBIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
CVI Holdings, LLC 226,916$383,4880.76%
HARBOURVEST PARTNERS LLC 335,709$567,3480.19%
ALLEN HOLDING INC /NY 687,571$1,161,9950.16%
ARMISTICE CAPITAL, LLC 3,476,000$5,874,4400.09%
Clearwater Capital Advisors, LLC 394,599$666,8730.08%
SHEETS SMITH WEALTH MANAGEMENT 273,879$462,8560.07%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$162,9720.06%
WEALTH EFFECTS LLC 53,500$90,4150.04%
Virtus ETF Advisers LLC 34,461$58,2390.04%
FISHMAN JAY A LTD/MI 162,000$273,7800.04%
View complete list of IMMUNITYBIO INC shareholders